Find your next paid study

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT07793253

~$75 – $2,000

Actual pay is set by the research site.

Microbiome Determinants of Adverse Effects of Stereotactic Radiosurgery

This prospective observational study will investigate the relationship between the gut microbiome and adverse effects following stereotactic radiosurgery (SRS)…

Adverse Radiation EffectsRadiation Necrosis

University of ChicagoNCT07767981

Actual pay is set by the research site.

Advanced or Metastatic Colorectal Cancer

A Phase 1b/2, Open-Label Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

The purpose of this study is to assess the anti-tumor activity of amivantamab as a monotherapy (Cohorts A, B, and C), to assess the recommended phase 2 combina…

Janssen Research & Development, LLCNCT05379595

Actual pay is set by the research site.

Effect of Testosterone on Brain Imaging and Headache in Transmasculine Adolescents

Transmasculine youth (female sex assigned at birth, male gender identity) who begin clinical gender affirming hormone therapy (GAHT) with testosterone (T) may …

Gender IdentityGender Dysphoria in Adolescents and AdultsHeadache+1 more

University of Colorado, DenverNCT06670053

Actual pay is set by the research site.

Observational

Application to Predict Neonatal Apnea With Bradycardia (APNeA Study)

This purpose of this study is to reduce or stop apneas and bradycardias in pre-term infants, before they occur using gentle stimulation.

Apnea NeonatalBradycardia Neonatal

University of Alabama at BirminghamNCT06852053

Actual pay is set by the research site.

Phase 2

Intravesical Gemcitabine and Docetaxel for High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study (GEMDOCE-BU)

The goal of this clinical trial is to learn whether a combination of two chemotherapy drugs, Gemcitabine and Docetaxel, can treat high-grade non-muscle-invasiv…

Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more

Michael A. O'DonnellNCT07322263

~$75 – $3,000

Actual pay is set by the research site.

Dystonia Genotype-Phenotype Correlation: A Study to Identify Additional Genetic Associations That Contribute to Specific Dystonic Phenotypes

The purpose of this study is to (1) investigate the effect of known dystonia-causing mutations on brain structure and function, to (2) identify structural brai…

DystoniaDystonia; IdiopathicDystonia, Primary+19 more

University of Texas Southwestern Medical CenterNCT03428009

Actual pay is set by the research site.

Observational

Can Fidgeting Lead to Enhanced Attention and Emotional Regulation in ADHD?

This project will study how fidgeting relates to cognitive and emotional functioning in adults with attention-deficit/hyperactivity disorder (ADHD). It will de…

ADHD

University of California, DavisNCT04526600

Actual pay is set by the research site.

A Phase 1 Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors With BRCA1/2 Mutations or Other DDR Deficiencies or High Replication Stress.

The goal of this interventional study is to evaluate the safety and tolerability of escalating doses of FORX-428 as monotherapy in patients with select advance…

Advanced Solid Tumors

FoRx Therapeutics AGNCT07356453

Actual pay is set by the research site.

Metastatic Hepatocellular CarcinomaSolid TumorsSolid Tumor, Adult+8 more

A Multicenter, Open-label, First-in-Human Study of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

A Phase 1 study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamic (PD), and preliminary antitumor activity of TYRA-430 in cancers wi…

Tyra Biosciences, IncNCT06915753

Actual pay is set by the research site.

Leukemia, Myeloid, ChronicMyeloid LeukemiaChronic Myeloid Leukemia+2 more

A Phase Ib Study of the Pharmacokinetics, Safety and Efficacy of Orally Administered HQP1351 in Subjects With Refractory Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (Ph+ ALL)

A multi-center, open-label, randomized, phase Ib study to evaluate the pharmacokinetics (PK) of HQP1351 and to determine the recommended phase 2 dose (RP2D) of…

Ascentage Pharma Group Inc.NCT04260022

Actual pay is set by the research site.

Phase 2

RiMO-HNC-NEO1: Phase 2 Study of RiMO-301 and Hypofractionated Radiotherapy With Pembrolizumab for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck Cancer

The primary objective is to evaluate major pathologic response after RiMO-301 with hypofractionated radiotherapy and a PD-1 inhibitor (pembrolizumab), as asses…

Head and Neck CancerHead CancerNeck Cancer